H ydrocepHalus is the most common condition treated by pediatric neurosurgeons. Successful management with cerebrospinal fluid shunt systems began after Nulsen and Spitz placed the first implantable shunt in 1949, using a stainless steel ball-valve system. 34 Over the next 2 decades, shunt systems evolved to include distal slit valves, proximal slit valves, and diaphragm valves. The subsequent development of artificial valves and silicone tubing advanced shunt design dramatically. Simple differential pressure valves were initially engineered followed by a second generation of valves that included autoregulating, adjustable, antisiphon, and gravitational components.
siphon control characteristics. Shunt system design has evolved along with attempts to minimize failure rates. The initial use of simple differential pressure valves led to concerns about the disadvantages of siphoning and associated shunt obstruction, subdural hematoma, slit ventricle syndrome, overdrainage, and craniosynostosis. In an attempt to minimize these complications, antisiphon devices have been developed and integrated into shunt systems as intrinsic to the valve mechanism or as separate devices. The antisiphon device is designed to provide progressive resistance to flow to counteract the siphoning that occurs when negative pressure is exerted with vertical positioning. The later development of programmable valves allowed for purposeful alterations in valve function to be made without a surgical procedure.
The purpose of this evidence-based review is to critically evaluate available data on the efficacy of comparable shunt components to determine if one shunt component is superior to another. Additionally, we created evidencebased recommendations on the selection of shunt components based on the strength of the available data. Most of the available evidence focuses on the comparison of shunt valve designs. Study outcome variables accepted for the purposes of this review included shunt survival, shunt complications, development of slit ventricle syndrome, and development of signs or symptoms of overdrainage.
Methods

Search Criteria
The US National Library of Medicine (PubMed/ MEDLINE) and the Cochrane Database of Systematic Reviews were queried for the period January 1966 through March 2012 using MeSH headings and key words relevant to shunt system components as detailed below. 
Search Terms
Search Results
The search yielded 269 abstracts, which were then reviewed for relevance to the demonstration of superiority of 1 shunt component over another. Forty-three articles were recalled for full-text review. Predetermined inclusion and exclusion criteria were used to review each of these articles in detail. Twenty-two articles were included in the final evidentiary table. Reasons for exclusion of fulltext articles included the absence of a valid comparison group (n = 14), [1] [2] [3] [7] [8] [9] [10] 12, 13, 20, 25, 26, 28, 35 the absence of a valid outcome variable (n = 4), 14, 18, 22, 32 invalid study design (n = 2), 30, 31 and redundant patient population (n = 1) (Fig. 1) . 5 For each article included in the evidentiary table, the study type, summary findings, and major conclusions were recorded, and a preliminary data class was assigned. The Pediatric Hydrocephalus Systematic Review and Evidence-Based Guidelines Task Force met to discuss the ranking of the evidence and the classification of data. Recommendations were then made based on the strength of the data in the evidentiary table (Table 1 ). In these discussions, if disagreement was encountered among Task Force members, a blinded vote was held and a consensus or majority opinion was reached.
Results
The review process identified 1 Class I study, 11 Class II studies, and 10 Class III studies.
Only one included article was rated as a Class I study, Kestle et al. (2000) , 19 in which the investigators performed a randomized controlled trial comparing 3 kinds of valves: all types of standard differential pressure valves, a Delta valve (Medtronic) with an antisiphon mechanism, and an Orbis-Sigma valve (Cordis) with a variable-resistance and flow-limiting mechanism. Three hundred fortyfour patients were randomly assigned to a valve type and followed up until the time of first shunt failure. Assessed outcome variables included shunt obstruction, overdrainage, ventricular loculations, and infection. The investigators did not find a significant difference in shunt survival between the 3 valve types in either the short-term (Drake 1998 5 ) or extended 19 follow-up. Eleven Class II studies 4, 11, 15, 21, 23, 24, 27, 33, 36, 41, 44 in which differing valve types were compared also failed to demonstrate a superior valve when shunt survival was assessed. Jain et al. 15 (2000) conducted a prospective cohort study in which they compared shunts using a standard differential pressure valve with a Delta (Medtronic) flowregulating valve. The authors found no significant difference in overall shunt survival (p = 0.72), with a 5-year survival rate of 58.6% for the differential pressure valves and 58.7% for the Delta valves. The authors did note a relative difference between the 2 groups in the incidence of overdrainage and infection. The differential pressure valve was associated with 4 cases of post-shunt subdural effusion or slit ventricle syndrome, while the Delta valve was associated with only 1 case of subdural effusion. The Delta valve group had 3 infections, whereas the differential pressure valve group had no infections. Warf et al. 44 (2005) conducted a prospective randomized trial in which they compared the Codman-Hakim microprecision valve with the more affordable Chhabra valve. Ninety children were evaluated after randomization for shunt malfunction, shunt migration, and wound complication. No significant differences in outcome variables were demon-J Neurosurg: Pediatrics / Volume 14 / November 2014 strated between the 2 groups. Smely and Van Velthoven (1997) conducted a retrospective cohort review in which they compared 66 infants who underwent placement of a ventriculoperitoneal Cordis Orbis-Sigma valve system with 53 patients who underwent placement of a ventriculoatrial Codman Holter Valve shunt system. 41 Forty-eight percent of patients with the Orbis-Sigma valve required one or more revisions while 98.1% of patients with the Holter Valve required 1 or more revisions (p < 0.001). The difference in distal placement of the shunt system is a confounding factor when comparing valve types in this study.
Antisiphon Mechanism
Three Class II studies evaluating the antisiphon mechanism were included in our review. Liniger et al. 23 (2003) studied 27 infants in a prospective cohort study in which a PS Medical medium pressure, flow-controlled valve was compared with a PS Medical 1.0 Delta valve with an antisiphon mechanism. The authors found a lower incidence of slit ventricle syndrome in the Delta valve group (6.25%) than in the flow-controlled valve group (9%); however this finding did not reach statistical significance (p > 0.99). The incidence of shunt revision was also lower in the Delta group (0.12 revisions/patient/year) than in the flow-controlled valve group (0.19 revisions/ patient/year), a finding that also failed to reach statistical significance (p = 0.75). Khan et al. 21 (2010) studied the role of the antisiphon mechanism in a randomized controlled trial. Forty patients undergoing shunt placement were randomized to receive a differential pressure valve with an antisiphon device (Vygon shunt) or a differential valve without an antisiphon device (Chhabra or Ceredrain shunts). Shunt blockage, shunt infection, overdrainage, loculated ventricles, and occipitofrontal circumference were assessed in the 2 groups. No end point variables demonstrated a statistically significant difference. Overdrainage complications occurred in 10% of the patients in the group without an antisiphon device as opposed to 0% in the group with an antisiphon device (p = 0.48). A slightly higher infection and obstruction rate was noted in the antisiphon group. In a retrospective cohort study of 4 (2000) assessed shunt survival and the development of subdural collection in patients treated with a Delta valve shunt with antisiphon function and in patients treated with one of 2 differential pressure valves without antisiphon control. In a comparison of the 3 groups, no significant difference was found.
The Class III studies that assessed the antisiphon mechanism include a retrospective review by Gruber et al. 6 (1984) , in which the authors evaluated 41 patients before and after primary or secondary placement of an antisiphon device. In the secondary placement group fewer complications and proximal catheter obstructions were noted after placement of such a device. However, no statistical analysis was provided by the authors to demonstrate the significance of their findings. In a retrospective cohort review of 101 patients who underwent shunt placement, Virella et al. 43 (2002) reported no significant differences between patients who underwent placement of a distal slit valve and patients who underwent placement of a Delta valve with an antisiphon component. The authors assessed the number of revisions, infections, and evidence of overdrainage, and reported that 31% of patients in the distal slit valve group required a single shunt revision and 8% required a second revision, whereas 30% of patients in the Delta valve group required a single revision and 20% required a second. Kaiser et al. 16 (1997) reported a prospective but incompletely described comparison study between a conventional medium pressure valve and the Delta valve. The authors found no difference in the number of shunt revisions.
Slit Ventricles
Kan et al. 17 (2007) conducted a retrospective review of 244 patients with at least 1 year of follow-up after primary shunt placement with a differential pressure valve, a Delta valve, or an Orbis-Sigma valve. Variables associated with the development of slitlike ventricles included patient age (younger age at insertion was associated with a higher incidence of slitlike ventricles; p = 0.09), etiology (trauma, infection, and aqueductal stenosis were associated with a higher incidence of slitlike ventricles), and valve type (10.8% of patients with differential pressure valves, 10.5% with Delta valves, and 3.6% with OrbisSigma valves developed slitlike ventricles; p = 0.007). This article suggests that a slower reduction in ventricle size and slower flow may lead to larger ventricles after shunt placement. Slit ventricle syndrome was not directly assessed; rather, the radiographic appearance of slitlike ventricles was used as a surrogate outcome.
Programmable Valves
Five Class II studies 11, 24, 27, 33, 36 evaluated programmable valves. Pollack et al. 36 (1999) conducted a multicenter randomized controlled trial in which they compared the programmable Codman Hakim valve to the surgeon's choice of any conventional valve. The authors demonstrated comparable efficacy and safety with no statistically significant difference in shunt survival between the experimental and control groups.
Hatlen et al. (2012) published an analysis of program- The higher patency rate of the Pudenz-Heyer valve was statistically significant (p < 0.001).
* ASD = antisiphon device; DPV = differential pressure valve; ETV = endoscopic third ventriculostomy; pt = patient; VP = ventriculoperitoneal. 27 The authors found that programmable valve placement was associated with a reduced risk of both overall shunt revision (35% vs 54% in the nonprogrammable group; p = 0.016) and proximal shunt obstruction (12% vs 28% in the nonprogrammable group; p = 0.006). Notarianni et al. 33 (2009) found no significant difference in a retrospective review of 253 patients who underwent shunt placement with either a programmable (Strata or Codman Hakim) or nonprogrammable (pressure-controlled or not specified) valve. The failure rate among the programmable valve group was 76.1%, and that among the differential pressure valve group was 80.0% (p = 0.11).
Other Comparison Groups
Several Class III studies comparing variable shunt valves were included in the review. Miranda et al. 29 (2011) describe a retrospective review of 103 patients who received shunts for preterm-related posthemorrhagic hydrocephalus. The authors reported a significantly higher rate of obstruction in patients weighing more than 2000 g who were treated with a fixed medium pressure valve (6 of 8 patients) than in those who were treated with a fixed low pressure valve (12 of 39 patients) (p = 0.040). Contrary findings were reported by Robinson et al. (2002) in a retrospective analysis of shunt malfunction variables in 158 patients. 38 Valve opening pressure was the only significant controllable factor found to be associated with shunt malfunction. The 5-year shunt failure rate was 72% in the no valve or low pressure valve group and 47% in the medium or high pressure valve group (p = 0.0005).
Sainte-Rose et al. 39 (1991) reviewed the charts of 1719 patients with shunted hydrocephalus to assess mechanical complications. These authors found that the flanged ventricular catheter was associated with a higher risk of proximal occlusion (p < 0.04), open-ended distal catheters were associated with fewer distal obstructions (log-rank p < 0.0003), and shunts with proximal medium pressure valves were less likely to malfunction than shunts with distal slit valves (p < 0.000002). Tuli et al. 42 (2000) did not find valve type to be associated with shunt malfunction in a post hoc analysis of a prospective cohort of 839 patients who underwent primary shunt insertions. No association between shunt malfunction and any component of the shunt hardware was reported in that study.
Ramadwar et al. 37 (1997) retrospectively compared the efficacy of the Delta valve with the Heyer-Shulte Multi-Purpose valve in 28 patients. Sixty-nine percent of patients with the Delta valve required revision, compared with 53% of patients with the Multi-Purpose valve. The sample size in that study was small, and the data did not reach statistical significance. In an older paper by Serlo et al. 40 (1986), a retrospective review of 148 children was conducted to compare the Pudenz-Heyer valve with the Cordis Hakim valve. No significant difference was found in overall shunt efficacy, although significance was demonstrated in a higher rate of valve patency on the part of the Pudenz-Heyer valve (p < 0.001).
Excluded Studies
The Task Force excluded 21 articles recalled for fulltext review from the final evidentiary table. The majority of excluded papers did not include a comparison group or control group. [1] [2] [3] [7] [8] [9] [10] 12, 13, 20, 25, 26, 28, 35 Other reasons for exclusion included invalid study design (questionnaire survey), 30, 31 redundant patient population 5 (only the paper with the longest reported follow-up was included), and absence of a valid outcome variable (change in ventricle size, development of spinal canal stenosis, historical description, and frequency of hospital visits). 14, 18, 22, 32 Conclusions recommendation: There is insufficient evidence to demonstrate an advantage of one shunt hardware design over another for the treatment of pediatric hydrocephalus. Current designs described in the evidentiary tables are all treatment options. strengtH of recommendation: Level I, high degree of clinical certainty.
recommendation: There is insufficient evidence to recommend the use of a programmable valve versus a nonprogrammable valve. Programmable and nonprogrammable valves are both options for the treatment of pediatric hydrocephalus. strengtH of recommendation: Level II, moderate degree of clinical certainty.
The available literature in which one shunt component is compared with another does not demonstrate a clear superiority of one over another. Higher rates of overdrainage were seen with standard differential pressure valves; however, the outcome variables studied in the comparisons of these groups with other shunt mechanisms failed to demonstrate statistical significance. While valves with antisiphon mechanisms may be superior in preventing overdrainage complications, no statistically significant data exist in the current medical literature to support this trend.
The studies assessing programmable versus nonprogrammable valves demonstrated either no statistically significant differences or contrary outcomes, pointing to the need for long-term prospective controlled analysis of this issue. Class III data demonstrating poorer function of distal slit valves in comparison with a proximal valve are described and are consistent with the contemporary decrease in utilization of the former type of shunt system.
Many contemporary valve designs exist despite major deficiencies in long-term clinical evaluation. Well-designed comparison studies with clearly defined outcome variables and appropriate stratification of patient variables are needed to further investigate the appropriate clinical utilization of these valves. Accessing the necessary patient volume required to reach significance and balancing industry interests with trial integrity may be significant barriers to pursuing needed studies; however, as increasingly expensive and complex valves become available for clinical use, these studies will become imperative. CNS, for her contributions; Pamela Shaw, research librarian, for her assistance with the literature searches; Kevin Boyer for his assistance with data analysis; and Sue Ann Kawecki for her assistance with editing.
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